Compounds > n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine
Page last updated: 2024-09-03

n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine and Lung Diseases

n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine has been researched along with Lung Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cocci, F; Giani, L; Miniati, M; Paci, A; Pistolesi, M1

Other Studies

1 other study(ies) available for n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine and Lung Diseases

ArticleYear
Evaluation of non-respiratory function of the human lung by HIPDM lung scanning.
    Clinical physiology (Oxford, England), 1992, Volume: 12, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Biological Transport, Active; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Kinetics; Lung; Lung Diseases; Male; Middle Aged; Mitochondria; Rabbits; Radionuclide Imaging; Tissue Distribution

1992